These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 20416365
1. Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state (13)C CPMAS NMR spectroscopy. Virtanen T, Maunu SL. Int J Pharm; 2010 Jul 15; 394(1-2):18-25. PubMed ID: 20416365 [Abstract] [Full Text] [Related]
2. Solid-state NMR in the analysis of drugs and naturally occurring materials. Paradowska K, Wawer I. J Pharm Biomed Anal; 2014 May 15; 93():27-42. PubMed ID: 24173236 [Abstract] [Full Text] [Related]
6. PCA-CR analysis of dissolution profiles. A chemometric approach to probe the polymorphic form of the active pharmaceutical ingredient in a drug product. Maggio RM, Castellano PM, Kaufman TS. Int J Pharm; 2009 Aug 13; 378(1-2):187-93. PubMed ID: 19477254 [Abstract] [Full Text] [Related]
7. Multinuclear solid state NMR investigation of two polymorphic forms of ciprofloxacin-saccharinate. Garro Linck Y, Chattah AK, Graf R, Romañuk CB, Olivera ME, Manzo RH, Monti GA, Spiess HW. Phys Chem Chem Phys; 2011 Apr 14; 13(14):6590-6. PubMed ID: 21384011 [Abstract] [Full Text] [Related]
8. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy. Heinz A, Strachan CJ, Gordon KC, Rades T. J Pharm Pharmacol; 2009 Aug 14; 61(8):971-88. PubMed ID: 19703341 [Abstract] [Full Text] [Related]
9. Quantitation of crystalline and amorphous forms of anhydrous neotame using 13C CPMAS NMR spectroscopy. Offerdahl TJ, Salsbury JS, Dong Z, Grant DJ, Schroeder SA, Prakash I, Gorman EM, Barich DH, Munson EJ. J Pharm Sci; 2005 Dec 14; 94(12):2591-605. PubMed ID: 16258988 [Abstract] [Full Text] [Related]
10. Applications of NIR spectroscopy to monitoring and analyzing the solid state during industrial crystallization processes. Févotte G, Calas J, Puel F, Hoff C. Int J Pharm; 2004 Apr 01; 273(1-2):159-69. PubMed ID: 15010140 [Abstract] [Full Text] [Related]
12. Improved solid-state NMR quantifications of active principles in pharmaceutical formulations. Sanchez S, Ziarelli F, Viel S, Delaurent C, Caldarelli S. J Pharm Biomed Anal; 2008 Aug 05; 47(4-5):683-7. PubMed ID: 18479881 [Abstract] [Full Text] [Related]
13. New perspectives of 19F MAS NMR in the characterization of amorphous forms of atorvastatin in dosage formulations. Brus J, Urbanova M, Sedenkova I, Brusova H. Int J Pharm; 2011 May 16; 409(1-2):62-74. PubMed ID: 21356299 [Abstract] [Full Text] [Related]
14. Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using 19F solid-state NMR and powder X-ray diffraction. Liu J, Nagapudi K, Kiang YH, Martinez E, Jona J. Drug Dev Ind Pharm; 2009 Aug 16; 35(8):969-75. PubMed ID: 19360510 [Abstract] [Full Text] [Related]
17. Characterization of solid polymer dispersions of active pharmaceutical ingredients by 19F MAS NMR and factor analysis. Urbanova M, Brus J, Sedenkova I, Policianova O, Kobera L. Spectrochim Acta A Mol Biomol Spectrosc; 2013 Jan 01; 100():59-66. PubMed ID: 22421443 [Abstract] [Full Text] [Related]
18. Application of 13C CPMAS NMR for qualitative and quantitative characterization of carvedilol and its commercial formulations. Zielińska-Pisklak M, Pisklak DM, Wawer I. J Pharm Sci; 2012 May 01; 101(5):1763-72. PubMed ID: 22331650 [Abstract] [Full Text] [Related]
19. Comparability of composition of carbon functional groups in humic acids between inverse-gated decoupling and cross polarization/magic angle spinning 13C nuclear magnetic resonance techniques. Watanabe A, Fujitake N. Anal Chim Acta; 2008 Jun 16; 618(1):110-5. PubMed ID: 18501252 [Abstract] [Full Text] [Related]